个人简历

江建新：博士、博士后，教授、主任医师，武汉大学人民医院肝胆外科，武汉大学博士生导师，贵州医科大学兼职博导； 科研情况：作为项目负责人承担国家自然科学基金3 项（地区基金1项，面上项目2项）、中国博士后基金 1项、省市级基金课题等 4 项。发表学术论文50多篇，其中SCI收录论文26篇，参编《肝内外胆管扩张诊断治疗学》、《曾宪九胰腺病学》。

研究领域

胰腺癌侵袭转移的分子机制""

近期论文

1.Jiang J, Yu C, Chen M, Zhang H, Tian S, Sun C. Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype. Oncotarget. 2015 Feb 20;6(5):2767-78.
2.Jiang J, Li Z, Yu C, Chen M, Tian S, Sun C. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Cancer Lett. 2015 Jan 28;356(2 PtB):962-70.
3.Jiang J, Zhang Y, Guo Y, Yu C, Chen M, Li Z, Tian S, Sun C. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation. Oncotarget. 2015 Mar 20;6(8):6359-72.
4.Jiang J, Chen H, Yu C, Zhang Y, Chen M, Tian S, Sun C. The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles. Nanomedicine (Lond). 2015 Jul;10(12):1863-79.
5. Wang J, Guo XJ, Ding YM, Jiang JX. miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer. World J Gastroenterol. 2017 Mar 7;23(9):1594-1601.
6.Yu C, Wang M, Chen M, Huang Y, Jiang J. Upregulation of microRNA‑138‑5p inhibits pancreatic cancer cell migration and increases chemotherapy sensitivity. Mol Med Rep.2015 Jul 2.
7.Yu C, Wang M, Li Z, Xiao J, Peng F, Guo X, Deng Y, Jiang J, Sun C. MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1. Cell Oncol (Dordr). 2015 Jun;38(3):173-81.
8.Chen M, Wang M, Xu S, Guo X, Jiang J.. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Oncotarget. 2015 Dec 29;6(42):44466-79.
9.Li X, Zhu F, Jiang J, Sun C, Zhong Q, Shen M, Wang X, Tian R, Shi C, Xu M, Peng F, Guo X, Hu J, Ye D, Wang M, Qin R.. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells. Autophagy. 2016 Jun 16:1-17.
10.Guo X, Zheng L, Jiang J, Zhao Y, Wang X, Shen M, Zhu F, Tian R, Shi H, Xu M, Li X, Peng F, Zhang H, Feng Y, Xie Y, Xu X, Jia W, He R, Xie C, Hu J, Ye D, Wang M, Qin R. Blocking NF-κB is essential for the immunotherapeutic effect of recombinant IL-18 in pancreatic cancer. Clin Cancer Res. 2016 Jun 13..
11.Wang J, Guo X, Xie C, Jiang J. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway. Br J Cancer. 2017 Jun 8.
12.Tian S, Guo X, Yu C, Sun C, Jiang J. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1. Oncotarget. 2017 Feb 14;8(7):11071-11082.
13. Xianfei Zhou, Xingjun Guo, Meiyuan Chen, Chencheng Xie, and Jianxin Jiang*； HIF-3a Promotes Metastatic Phenotypes in Pancreatic Cancer by Transcriptional Regulation of the RhoC–ROCK1 Signaling Pathway；Mol Cancer Res, 2018,16(1):124-134.
中华医学会外科学分会第十六、十七、十八届中青年委员，中华医学会外科学分会第十七胰腺外科组委员，中国医疗保健国际交流促进会（医促会）胰腺疾病分会委员、胰腺疾病微创治疗学组委员，中国研究型医院学会胰腺疾病专业委员会委员、微创胰腺治疗学组委员，中国医师协会胰腺癌专业委员会委员，中国医师协会外科医师分会加速康复外科委员会，中国医学装备协会基础装备分会委员，中国抗癌协会肿瘤标志专业委员会非编码RNA与肿瘤研究专委会常委，湖北省抗癌协会胰腺癌专业委员常委，湖北省肝胆疾病学会理事，《中华内分泌外科杂志》编委，《中华肝胆外科杂志》通讯编委，《世界华人消化杂志》编委、《Annals of surgery》(中文版)通讯编委、《医学参考报》编委，《中华临床医师杂志》 、 《中华实验外科杂志》 、《临床肝胆杂志》审稿人。